Literature DB >> 27192938

Human cytomegalovirus pUL10 interacts with leukocytes and impairs TCR-mediated T-cell activation.

Luca Bruno1, Mirko Cortese1, Giuseppina Monda1, Michela Gentile1, Stefano Calò1, Francesca Schiavetti1, Luisanna Zedda1, Elena Cattaneo1, Diego Piccioli1, Mary Schaefer2, Eugenio Notomista3, Domenico Maione1, Andrea Carfì2, Marcello Merola1,3, Yasushi Uematsu1.   

Abstract

Human cytomegalovirus (HCMV) is known to exert suppressive effects on the host immune system through expression of various viral genes, thus directly and indirectly affecting antiviral immunity of the infected individuals. We report here that HCMV UL10 encodes a protein (pUL10) with immunosuppressive properties. UL10 has been classified as a member of the HCMV RL11 gene family. Although pUL10 is known to be dispensable for viral replication in cultured cells, its amino-acid sequence is well conserved among different HCMV isolates, suggesting that the protein has a crucial role in viral survival in the host environment. We show that pUL10 is cleaved from the cell surface of fibroblasts as well as epithelial cells and interacts with a cellular receptor ubiquitously expressed on the surface of human leukocytes, demonstrated by ex vivo cell-based assays and flow cytometric analyses on both lymphoid cell lines and primary blood cells. Furthermore, preincubation of peripheral blood mononuclear cells with purified pUL10 ectodomain results in significantly impaired proliferation and substantially reduced pro-inflammatory cytokine production, in particular in CD4+ T cells upon in vitro T-cell stimulation. The inhibitory effect of pUL10 is also observed on antigen receptor-mediated intracellular tyrosine phosphorylation in a T-cell line. Based on these observations, we suggest that pUL10 is a newly identified immunomodulatory protein encoded by HCMV. Further elucidation of interactions between pUL10 and the host immune system during HCMV may contribute to finding ways towards new therapies for HCMV infection.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27192938     DOI: 10.1038/icb.2016.49

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  47 in total

1.  A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2.

Authors:  V S Goldmacher; L M Bartle; A Skaletskaya; C A Dionne; N L Kedersha; C A Vater; J W Han; R J Lutz; S Watanabe; E D Cahir McFarland; E D Kieff; E S Mocarski; T Chittenden
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

Review 2.  Positive and negative regulation of T-cell activation through kinases and phosphatases.

Authors:  Tomas Mustelin; Kjetil Taskén
Journal:  Biochem J       Date:  2003-04-01       Impact factor: 3.857

3.  Functional map of human cytomegalovirus AD169 defined by global mutational analysis.

Authors:  Dong Yu; Maria C Silva; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-30       Impact factor: 11.205

4.  The human cytomegalovirus UL36 gene controls caspase-dependent and -independent cell death programs activated by infection of monocytes differentiating to macrophages.

Authors:  A Louise McCormick; Linda Roback; Devon Livingston-Rosanoff; Courtney St Clair
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

5.  Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcgamma receptor homologs.

Authors:  Ramazan Atalay; Albert Zimmermann; Markus Wagner; Eva Borst; Christine Benz; Martin Messerle; Hartmut Hengel
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

6.  A novel viral transcript with homology to human interleukin-10 is expressed during latent human cytomegalovirus infection.

Authors:  Christina Jenkins; Allison Abendroth; Barry Slobedman
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

7.  An essential role for ectodomain shedding in mammalian development.

Authors:  J J Peschon; J L Slack; P Reddy; K L Stocking; S W Sunnarborg; D C Lee; W E Russell; B J Castner; R S Johnson; J N Fitzner; R W Boyce; N Nelson; C J Kozlosky; M F Wolfson; C T Rauch; D P Cerretti; R J Paxton; C J March; R A Black
Journal:  Science       Date:  1998-11-13       Impact factor: 47.728

8.  Processing and MHC class I presentation of human cytomegalovirus pp65-derived peptides persist despite gpUS2-11-mediated immune evasion.

Authors:  Katrin Besold; Nadine Frankenberg; Sandra Pepperl-Klindworth; Jürgen Kuball; Matthias Theobald; Gabriele Hahn; Bodo Plachter
Journal:  J Gen Virol       Date:  2007-05       Impact factor: 3.891

Review 9.  Human cytomegalovirus immunity and immune evasion.

Authors:  Sarah E Jackson; Gavin M Mason; Mark R Wills
Journal:  Virus Res       Date:  2010-11-05       Impact factor: 3.303

10.  The human cytomegalovirus UL11 protein interacts with the receptor tyrosine phosphatase CD45, resulting in functional paralysis of T cells.

Authors:  Ildar Gabaev; Lars Steinbrück; Claudia Pokoyski; Andreas Pich; Richard J Stanton; Reinhard Schwinzer; Thomas F Schulz; Roland Jacobs; Martin Messerle; Penelope C Kay-Fedorov
Journal:  PLoS Pathog       Date:  2011-12-08       Impact factor: 6.823

View more
  6 in total

1.  A Prominent Role of the Human Cytomegalovirus UL8 Glycoprotein in Restraining Proinflammatory Cytokine Production by Myeloid Cells at Late Times during Infection.

Authors:  Natàlia Pérez-Carmona; Pablo Martínez-Vicente; Domènec Farré; Ildar Gabaev; Martin Messerle; Pablo Engel; Ana Angulo
Journal:  J Virol       Date:  2018-04-13       Impact factor: 5.103

2.  Identification and Functional Characterization of a Novel Fc Gamma-Binding Glycoprotein in Rhesus Cytomegalovirus.

Authors:  Philipp Kolb; Steven Sijmons; Matthew R McArdle; Husam Taher; Jennie Womack; Colette Hughes; Abigail Ventura; Michael A Jarvis; Christiane Stahl-Hennig; Scott Hansen; Louis J Picker; Daniel Malouli; Hartmut Hengel; Klaus Früh
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

Review 3.  Human Cytomegalovirus and Autoimmune Diseases: Where Are We?

Authors:  Francesca Gugliesi; Selina Pasquero; Gloria Griffante; Sara Scutera; Camilla Albano; Sergio Fernando Castillo Pacheco; Giuseppe Riva; Valentina Dell'Oste; Matteo Biolatti
Journal:  Viruses       Date:  2021-02-08       Impact factor: 5.048

4.  Deciphering the Potential Coding of Human Cytomegalovirus: New Predicted Transmembrane Proteome.

Authors:  Francisco J Mancebo; Marcos Parras-Moltó; Estéfani García-Ríos; Pilar Pérez-Romero
Journal:  Int J Mol Sci       Date:  2022-03-02       Impact factor: 5.923

5.  Human Cytomegalovirus Encodes a Novel FLT3 Receptor Ligand Necessary for Hematopoietic Cell Differentiation and Viral Reactivation.

Authors:  Lindsey B Crawford; Jung Heon Kim; Donna Collins-McMillen; Byeong-Jae Lee; Igor Landais; Christine Held; Jay A Nelson; Andrew D Yurochko; Patrizia Caposio
Journal:  MBio       Date:  2018-04-24       Impact factor: 7.867

6.  Mixed cytomegalovirus genotypes in HIV-positive mothers show compartmentalization and distinct patterns of transmission to infants.

Authors:  Juanita Pang; Jennifer A Slyker; Richard A Goldstein; Judith Breuer; Sunando Roy; Josephine Bryant; Claire Atkinson; Juliana Cudini; Carey Farquhar; Paul Griffiths; James Kiarie; Sofia Morfopoulou; Alison C Roxby; Helena Tutil; Rachel Williams; Soren Gantt
Journal:  Elife       Date:  2020-12-31       Impact factor: 8.140

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.